Table 4.
Measures | CIPN FoF+ | CIPN FoF− | Normal control |
P-value (Group difference) |
---|---|---|---|---|
Eyes-open condition | ||||
Ankle sway (deg2) | 2.60 ± 4.05 * | 1.85 ± 1.22 ‡ | 0.52 ± 0.34 |
P = .001 X2(2) = 14.659 |
Hip sway (deg2) | 1.84 ± 2.71 | 1.77 ± 1.79 ‡ | 0.59 ± 0.37 |
P = .036 X2(2) = 6.672 |
CoM sway (cm2) | 0.49 ± 0.87 | 0.31 ± 0.19 ‡ | 0.10 ± 0.09 |
P = .003 X2(2) = 11.684 |
Eyes-closed condition | ||||
Ankle sway (deg2) | 4.79 ± 6.44 | 2.98 ± 2.02 ‡ | 1.37 ± 1.09 |
P = .039 X2(2) = 6.499 |
Hip sway (deg2) | 2.45 ± 2.31 | 3.45 ± 3.34 | 1.32 ± 0.77 |
P = .076 X2(2) = 5.152 |
CoM sway (cm2) | 3.83 ± 9.50 * | 2.23 ± 2.88 ‡ | 0.25 ± 0.19 |
P = .001 X2(2) = 14.181 |
Note: Values are expressed as mean ± standard deviation.
Significant pairwise differences (p < .05) between the CIPN FoF+ and normal control groups.
Significant pairwise differences (p < .05) between the CIPN FoF+ and CIPN FoF− groups.
Significant pairwise differences (p < .05) between the CIPN FoF− and normal control groups.
Abbreviations: CIPN = chemotherapy-induced peripheral neuropathy; FoF = fear of falling; deg = degrees; cm = centimeters; CoM = center of mass.